Hydroxocobalamin Patent Expiration

Hydroxocobalamin is Used for the treatment of cyanide poisoning. It was first introduced by Btg International Inc in its drug Cyanokit on Dec 15, 2006. 6 different companies have introduced drugs containing Hydroxocobalamin.


Hydroxocobalamin Patents

Given below is the list of patents protecting Hydroxocobalamin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cyanokit US5834448 Dosage form of hydroxocobalamin and its use in cyanide poisoning Nov 14, 2016

(Expired)

Btg Intl



Hydroxocobalamin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydroxocobalamin Generic API Manufacturers

Several generic applications have been filed for Hydroxocobalamin. The first generic version for Hydroxocobalamin was by Bel Mar Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Abraxis Pharmaceutical Products and was approved on Approved Prior to Jan 1, 1982.

Given below is the list of companies who have filed for Hydroxocobalamin generic, along with the locations of their manufacturing plants worldwide.